Seong-Woo Kim

Seong-Woo Kim


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Retina
Verified
Journal Article
Closed access
SKSeong-Woo Kim
Seong-Woo Kim
JOJaeryung Oh
Jaeryung Oh
SKSoon-Sun Kwon
Soon-Sun Kwon
JYJunho Yoo
Junho Yoo
KHKuhl Huh
Kuhl Huh
To compare choroidal thicknesses among eyes with early age-related maculopathy (ARM), neovascular age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy. Patients with age-related maculopathy (37 eyes), neovascular age-related macular degeneration (24 eyes), polypoidal choroidal vasculopathy (12 eyes), and central serous chorioretinopathy (31 eyes) underwent spectral-domain optical coherence tomography evaluations using a choroid scanning protocol. A horizontal linear section comprising 50 averaged scans was obtained of each macula. The choroidal thickness was measured from the outer border of the retinal pigment epithelium to the inner scleral border. Twenty-nine subjects with healthy eyes served as a control group. Analysis of covariance tests were performed to evaluate the effects of various diagnoses on choroidal thickness after removal of variance (covariates = gender, age, and refractive error). Among the different covariates, age was associated with choroidal thickness (fovea: F = 12.067, P = 0.001). After controlling for age differences, the choroid was thicker in polypoidal choroidal vasculopathy (319.92 ± 68.66 μm) and central serous chorioretinopathy (367.81 ± 105.56 μm) patients than in controls (241.97 ± 66.37 μm) and age-related maculopathy patients (186.62 ± 64.02 μm). However, there were no significant differences in mean choroidal thickness between neovascular age-related macular degeneration (226.46 ± 102.87 μm) and any of the other diagnoses. The choroid was thicker in eyes with polypoidal choroidal vasculopathy or central serous chorioretinopathy than in control or age-related maculopathy groups.

7 October 2010 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
IOIn Kyung Oh
In Kyung Oh
SKSeong-Woo Kim
Seong-Woo Kim
JOJaeryung Oh
Jaeryung Oh
TLTae Soo Lee
Tae Soo Lee
KHKuhl Huh
Kuhl Huh
Purpose: To determine the relationship between the aqueous concentrations of inflammatory and angiogenic factors and the severity of diabetic retinopathy and diabetic macular edema. Methods: Aqueous samples were obtained from 50 eyes of diabetic patients and 28 eyes of nondiabetic subjects. The aqueous levels of inflammatory factors, including IL-1β, TNF-α, MCP-1, IP-10, IL-8, IL-6, and VEGF were measured with multiplex bead array assays. The aqueous levels of cytokines were investigated according to the severity of diabetic retinopathy and diabetic macular edema measured by optical coherence tomography. Results: The aqueous levels of MCP-1, IP-10, IL-8, and VEGF were higher in eyes of diabetic patients than in eyes of nondiabetic subjects. The aqueous levels of MCP-1 and IP-10 were elevated in eyes with severe NPDR and PDR compared to eyes with less severe DR and eyes of nondiabetic subjects. There was a trend toward elevated IL-8 levels in eyes with severe NPDR compared to eyes of nondiabetic subjects. The aqueous levels of VEGF were markedly elevated in eyes with PDR that had not received PRP compared to eyes with severe NPDR. Eyes with PDR that had received PRP treatment showed higher MCP-1 and IP-10 levels than eyes with PDR that had not received PRP treatment. The aqueous levels of IL-6 were positively correlated with TMV and CSMT in eyes with DR. Conclusions: Elevation of MCP-1, IP-10, and IL-8 levels in eyes with severe NPDR suggests that inflammatory change precedes the development of neovascularization in PDR. The positive correlation between the aqueous levels of IL-6 and macular thickness indicates that IL-6 may play a central role in the development of diabetic macular edema.

1 January 2012 in Korean Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
YEYoungsub Eom
Youngsub Eom
JOJaeryung Oh
Jaeryung Oh
SKSeong-Woo Kim
Seong-Woo Kim
KHKuhl Huh
Kuhl Huh
Eom Y, et al. Korean J Ophthalmol. 2012 Aug;26(4):260-264. https://doi.org/10.3341/kjo.2012.26.4.260

24 May 2012 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
JOJaeryung Oh
Jaeryung Oh
SYSun Mo Yang
Sun Mo Yang
YCYong Min Choi
Yong Min Choi
SKSeong-Woo Kim
Seong-Woo Kim
KHKuhl Huh
Kuhl Huh

1 January 2011 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
MCMinwook Chang
Minwook Chang
CYChungkwon Yoo
Chungkwon Yoo
SKSeong-Woo Kim
Seong-Woo Kim
YKYong Yeon Kim
Yong Yeon Kim

1 May 2009 in Ophthalmic Surgery, Lasers and Imaging Retina
Verified
Journal Article
Closed access
SKSeong-Woo Kim
Seong-Woo Kim
JOJaeryung Oh
Jaeryung Oh
IOIn Kyung Oh
In Kyung Oh
KHKuhl Huh
Kuhl Huh
Retinal pigment epithelial tears may occur after photodynamic therapy (PDT) in various diseases. The authors report a case of a retinal pigment epithelial tear after half light intensity (300 mW/cm 2 ) PDT in a large serous pigment epithelial detachment associated with chronic atypical central serous chorioretinopathy. A 52-year-old woman with a large serous pigment epithelial detachment associated with chronic atypical central serous chorioretinopathy in the left eye received her first PDT treatment using verteporfin with a spot size of 6,640 µm, a duration of 83 seconds, and half (300 mW/cm 2 ) of the standard 600 mW/cm 2 light intensity, where the delivered PDT light dose was only 25 J/cm 2 . Two weeks later, visual acuity improved to 20/30. However, a large crescent-shaped retinal pigment epithelial tear was found during fundus examination. Even 50% reduced light fluence PDT can produce a retinal pigment epithelial tear in pigment epithelial detachment associated with chronic atypical central serous chorioretinopathy. [Ophthalmic Surg Lasers Imaging 2009;40:300–303.]